SEC Filing Analysis: Invivyd, Inc. (IVVD)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Director Ian Sheffield filed an initial statement of beneficial ownership reporting zero shares upon joining the Board.
• Market Impact: Neutral; standard administrative compliance filing with no open-market transactions.

Company Information

Field	Value
Company	Invivyd, Inc.
Ticker Symbol	IVVD
CIK	0001832038
Industry	Biological Products (No Diagnostic Substances)

Insider Information

Field	Value
Name	Ian Sheffield
CIK	0001594410
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	3
Event Date	2026-08-30
Transaction Code	N/A
Security Type	None
Shares Involved	0
Price Per Share	N/A
Total Value	$0
Shares Owned After	0
Ownership Type	N/A

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0.00
% of Market Cap ($0.29B)	0.00%
Shares Transacted	0
% of Shares Outstanding (294.61M)	0.00%
Post-Transaction Ownership	0 shares (0.00%)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With Invivyd's market capitalization standing at $0.29 billion, an initial Form 3 filing reporting zero holdings presents no financial or dilutive impact.
• Ownership Concentration: The reporting person holds 0.00% of the 294,610,000 outstanding shares.
• Dilution Impact: None.

Market Impact Analysis

• Direction: Neutral
• Reasoning: Administrative initial ownership filing with no capital inflow, outflow, or equity dilution.
• Expected Volume Impact: Negligible to none.
• Sentiment Indicator: Neutral

Additional Context

• Timing: Effective as of August 30, 2026, and filed with the SEC on September 2, 2026.
• Special Circumstances: Accompanied by Exhibit 24.1 (Limited Power of Attorney for Section 16 filings).